BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 9360220)

  • 1. A comparison of low molecular weight heparin and low dose unfractionated heparin prophylaxis in subacute myelopathy.
    Spivack SB; Aisen ML
    J Spinal Cord Med; 1997 Oct; 20(4):402-5. PubMed ID: 9360220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
    Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
    Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dalteparin vs low-dose unfractionated heparin for prophylaxis against clinically evident venous thromboembolism in acute traumatic spinal cord injury: a retrospective cohort study.
    Worley S; Short C; Pike J; Anderson D; Douglas JA; Thompson K
    J Spinal Cord Med; 2008; 31(4):379-87. PubMed ID: 18959355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A probabilistic cost-effectiveness analysis of enoxaparin versus unfractionated heparin for the prophylaxis of deep-vein thrombosis following major trauma.
    Lynd LD; Goeree R; Crowther MA; O'Brien BJ
    Can J Clin Pharmacol; 2007; 14(2):e215-26. PubMed ID: 17652767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis of heparin therapy for preventing venous thromboembolism in acute spinal cord injury.
    Liu Y; Xu H; Liu F; Lv Z; Kan S; Ning G; Feng S
    Int J Surg; 2017 Jul; 43():94-100. PubMed ID: 28579397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Review of Two Heparin Prophylaxes for Trauma.
    Yu HD
    J Trauma Nurs; 2019; 26(5):263-269. PubMed ID: 31503200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost implications of low molecular weight heparins as prophylaxis following total hip and knee replacement.
    Bell GK; Goldhaber SZ
    Vasc Med; 2001; 6(1):23-9. PubMed ID: 11358156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of a low molecular weight heparin administered intravenously or subcutaneously in comparison with intravenous unfractionated heparin in the treatment of deep venous thrombosis. Certoparin-Study Group.
    Kirchmaier CM; Wolf H; Schäfer H; Ehlers B; Breddin HK
    Int Angiol; 1998 Sep; 17(3):135-45. PubMed ID: 9821025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of low-molecular-weight heparin, administered primarily at home, with unfractionated heparin, administered in hospital, and subcutaneous heparin, administered at home for deep-vein thrombosis.
    Belcaro G; Nicolaides AN; Cesarone MR; Laurora G; De Sanctis MT; Incandela L; Barsotti A; Corsi M; Vasdekis S; Christopoulos D; Lennox A; Malouf M
    Angiology; 1999 Oct; 50(10):781-7. PubMed ID: 10535716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of low-molecular-weight heparin versus unfractionated heparin to prevent pulmonary embolism following major trauma: A propensity-matched analysis.
    Byrne JP; Geerts W; Mason SA; Gomez D; Hoeft C; Murphy R; Neal M; Nathens AB
    J Trauma Acute Care Surg; 2017 Feb; 82(2):252-262. PubMed ID: 27906870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A tale of two centers: Is low-molecular-weight heparin really superior for prevention of posttraumatic venous thromboembolism?
    Checchi KD; Costantini TW; Badiee J; Berndtson AE; Calvo RY; Rooney AS; Wessels LE; Prieto JM; Sise CB; Sise MJ; Martin MJ; Bansal V
    J Trauma Acute Care Surg; 2021 Sep; 91(3):537-541. PubMed ID: 33901051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of location and low-molecular-weight heparin administration on deep vein thrombosis outcomes in trauma patients.
    Lee TH; Alonzo BJ; Differding J; Underwood SJ; Hamilton G; Kremenevskiy I; McNamara S; Schreiber MA
    J Trauma Acute Care Surg; 2013 Feb; 74(2):476-81. PubMed ID: 23354241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic and utilization outcomes associated with choice of treatment for venous thromboembolism in hospitalized patients.
    Knight KK; Wong J; Hauch O; Wygant G; Aguilar D; Ofman JJ
    Value Health; 2005; 8(3):191-200. PubMed ID: 15877591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Geerts WH; Pineo GF; Heit JA; Bergqvist D; Lassen MR; Colwell CW; Ray JG
    Chest; 2004 Sep; 126(3 Suppl):338S-400S. PubMed ID: 15383478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low molecular weight heparin (enoxaparin) compared with unfractionated heparin in prophylaxis of deep venous thrombosis and pulmonary embolism in patients undergoing hip replacement.
    Avikainen V; von Bonsdorff H; Partio E; Kaira P; Hakkinen S; Usenius JP; Kaaja R
    Ann Chir Gynaecol; 1995; 84(1):85-90. PubMed ID: 7645915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low molecular weight versus unfractionated heparin. A clinical and economic appraisal.
    Heaton D; Pearce M
    Pharmacoeconomics; 1995 Aug; 8(2):91-9. PubMed ID: 10155614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hospitalizations and Other Health Care Resource Utilization Among Patients with Deep Vein Thrombosis Treated with Rivaroxaban Versus Low-molecular-weight Heparin and Warfarin in the Outpatient Setting.
    Deitelzweig S; Laliberté F; Crivera C; Germain G; Bookhart BK; Olson WH; Schein J; Lefebvre P
    Clin Ther; 2016 Aug; 38(8):1803-1816.e3. PubMed ID: 27491278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of deep vein thrombosis with low molecular-weight heparin in patients undergoing total hip replacement. A randomized trial. The German Hip Arthroplasty Trial (GHAT) Group.
    Arch Orthop Trauma Surg; 1992; 111(2):110-20. PubMed ID: 1314065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the cost of preventing postoperative deep vein thrombosis with either unfractionated or low molecular weight heparin.
    Bergqvist D; Lindgren B; Mätzsch T
    Br J Surg; 1996 Nov; 83(11):1548-52. PubMed ID: 9014669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative prophylaxis of venous thromboembolism (VTE) in patients undergoing high ligation and stripping of the great saphenous vein (GSV).
    Wang H; Sun Z; Jiang W; Zhang Y; Li X; Wu Y
    Vasc Med; 2015 Apr; 20(2):117-21. PubMed ID: 25601917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.